Related Experiment Video
Updated: May 10, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Stimulant medication and substance use outcomes: a meta-analysis
Kathryn L Humphreys1, Timothy Eng, Steve S Lee
1Department of Psychology, University of California, Los Angeles, CA 90095, USA. k.humphreys@ucla.edu
Childhood stimulant medication for attention-deficit/hyperactivity disorder (ADHD) does not increase the risk of later substance use disorders. This meta-analysis found no significant difference in substance outcomes between treated and untreated children.
Area of Science:
- Neuroscience
- Psychiatry
- Public Health
Background:
- Attention-deficit/hyperactivity disorder (ADHD) is a common childhood disorder treated with psychostimulant medication.
- Controversy exists regarding whether stimulant treatment increases the risk of future substance use disorders.
- Previous research has yielded conflicting results on the long-term effects of stimulant medication on substance use.
Purpose of the Study:
- To conduct a meta-analysis of longitudinal studies examining the association between childhood stimulant medication treatment and later substance use and abuse or dependence.
- To synthesize evidence on the relationship between ADHD treatment and the risk of developing substance use disorders in adulthood.
Main Methods:
- Systematic literature search of studies published between 1980 and 2012 using review articles, PubMed, and listservs.
- Inclusion of longitudinal studies where medication treatment preceded substance outcome assessment.
- Extraction of odds ratios for various substance outcomes (alcohol, marijuana, nicotine, etc.) from 15 studies, encompassing 2565 participants.
Main Results:
- Random-effects models were used to estimate the overall association between stimulant treatment and substance outcomes.
- Analyses revealed comparable outcomes for substance use and abuse or dependence across all substance types between children with and without a history of medication treatment.
- No significant difference in the risk of substance use disorders was observed based on childhood stimulant medication history.
Conclusions:
- Childhood treatment for ADHD with stimulant medication neither protects against nor increases the risk of developing later substance use disorders.
- These findings contribute to the understanding of the long-term safety profile of psychostimulant treatment in ADHD.
- The results suggest that the benefits of stimulant treatment for ADHD outweigh potential risks related to substance use disorders.
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drug Dependence
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...

